| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0094-0143(05)70358-X |
| P698 | PubMed publication ID | 9048856 |
| P2093 | author name string | M S Pearle | |
| C Y Pak | |||
| L A Ruml | |||
| P2860 | cites work | Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation | Q71752154 |
| Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones | Q71800368 | ||
| Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria | Q71850295 | ||
| Dietary hypercalciuria in patients with calcium oxalate kidney stones | Q72158354 | ||
| Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers | Q72288120 | ||
| Uric acid nephrolithiasis in gout. Predisposing factors | Q72318681 | ||
| Five Years of Experience with Selective Therapy in Recurrent Calcium Nephrolithiasis | Q72390426 | ||
| Sodium-dependent idiopathic hypercalciuria in renal-stone formers | Q72560123 | ||
| Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis | Q72580222 | ||
| Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients | Q72641845 | ||
| The potential role of salt abuse on the risk for kidney stone formation | Q72818327 | ||
| Stone recurrences in kidneys made stone-free by percutaneous extraction | Q72879485 | ||
| LONG-TERM SURVEY OF 538 PATIENTS WITH UPPER URINARY TRACT STONE | Q76600783 | ||
| THE EFFECT OF ORAL PHOSPHATE IN PATIENTS WITH RECURRENT RENAL CALCULUS | Q78557724 | ||
| Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis | Q93578439 | ||
| Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation | Q93634031 | ||
| Treatment with with oestrogens of primary hyperparathyroidism in post-menopausal women | Q93716878 | ||
| Does medullary sponge kidney cause nephrolithiasis? | Q28300743 | ||
| Letter: Vitamin-C-induced hyperoxaluria | Q28317843 | ||
| Triamterene-Induced Nephrolithiasis | Q28328226 | ||
| Triamterene nephrolithiasis: renewed attention is warranted | Q28331859 | ||
| Calcium metabolism in acidotic patients induced by carbonic anhydrase inhibitors: responses to citrate | Q28335424 | ||
| Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones | Q34351568 | ||
| On the Hypocalciuric Action of Chlorothiazide | Q34466497 | ||
| Changes in Serum and Urinary Calcium during Treatment with Hydrochlorothiazide: Studies on Mechanisms | Q34496487 | ||
| Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria | Q34497702 | ||
| Urinary oxalate excretion after large intakes of ascorbic acid in man. | Q34716576 | ||
| Treatment of primary hyperoxaluria | Q35148251 | ||
| Environmental factors in the pathophysiology of recurrent idiopathic calcium urolithiasis (RCU), with emphasis on nutrition | Q36761697 | ||
| Renal handling of citrate | Q37983153 | ||
| Do thiazides reduce intestinal oxalate absorption?: a study in vitro using rabbit colon | Q38468489 | ||
| Urolithiasis. A study of its frequency | Q39218973 | ||
| The Association of Nephrolithiasis and Autosomal Dominant Polycystic Kidney Disease | Q39709590 | ||
| Use of phosphates in patients with calcareous renal calculi | Q39728298 | ||
| Prevention of calcium stones with thiazides | Q39728329 | ||
| Metabolic Effects of Parathyroidectomy in Asymptomatic Primary Hyperparathyroidism | Q39979431 | ||
| Selective effects of thiazide on intestinal absorption of calcium in absorptive and renal hypercalciurias | Q40125234 | ||
| The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers | Q40242843 | ||
| Micropuncture study of diuretic effects on sodium and calcium reabsorption in the dog nephron | Q40372728 | ||
| Clarification of the site of action of chlorothiazide in the rat nephron | Q40982108 | ||
| Should Recurrent Calcium Oxalate Stone formers become Vegetarians? | Q41033073 | ||
| Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias | Q41642468 | ||
| Effects of Therapy with Bendroflumethiazide in Patients with Recurrent Renal Calcium Stones | Q41727436 | ||
| Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder | Q41970406 | ||
| Urine composition and stone formation during treatment with acetazolamide | Q42215438 | ||
| Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis; relationship to citrate and calcium excretion | Q42238466 | ||
| The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism | Q44967187 | ||
| Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men. | Q46013347 | ||
| Prevention and treatment of kidney stones. Role of medical prevention | Q46825638 | ||
| Renal stone epidemiology: A 25-year study in Rochester, Minnesota | Q50536768 | ||
| Physicochemical effects of a new slow-release potassium phosphate preparation (UroPhos-K) in absorptive hypercalciuria. | Q51590295 | ||
| Trichlormethiazide and oral phosphate therapy in patients with absorptive hypercalciuria. | Q51622222 | ||
| Importance of dietary sodium in the hypercalciuria syndrome. | Q51649776 | ||
| Can citrate therapy prevent nephrolithiasis? | Q70582949 | ||
| Metabolic evaluation of nephrolithiasis in patients with medullary sponge kidney | Q70694573 | ||
| Effect of orange juice consumption on urinary stone risk factors | Q70736725 | ||
| Horseshoe Kidney and Urolithiasis | Q70768534 | ||
| Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers | Q70806087 | ||
| Is selective therapy of recurrent nephrolithiasis possible? | Q70930981 | ||
| Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol | Q70930986 | ||
| Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts | Q71042697 | ||
| The stone clinic effect in patients with idiopathic calcium urolithiasis | Q71108034 | ||
| Treatment of recurrent calcium stone formation with cellulose phosphate | Q71129975 | ||
| Evidence justifying a high fluid intake in treatment of nephrolithiasis | Q71256706 | ||
| Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis | Q71278209 | ||
| The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? | Q71311137 | ||
| Dietary influence on serum and urinary oxalate in healthy subjects and oxalate stone formers | Q71343989 | ||
| Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discriminant score | Q71386450 | ||
| Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. | Q51658667 | ||
| Some factors influencing the urinary excretion of oxalic acid in man. | Q51686201 | ||
| Randomized trial of allopurinol in the prevention of calcium oxalate calculi. | Q52870729 | ||
| Extraskeletal calcification complicating oral neutral-phosphate therapy. | Q53884233 | ||
| Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. | Q54444778 | ||
| Double-blind study with thiazide in recurrent calcium lithiasis | Q57228325 | ||
| The Frequency of Renal Stones within Great Britain in a Gouty and Non-gouty Population | Q66990005 | ||
| Primary hyperparathyroidism. A cause of hypercalciuria and renal stones in patients with medullary sponge kidney | Q67020860 | ||
| The Effects of Vegetable and Animal Protein Diets on Calcium, Urate and Oxalate Excretion | Q67254261 | ||
| A Detailed Evaluation of Oral Phosphate Therapy in Selected Patients With Primary Hyperparathyroidism* | Q67277725 | ||
| Incidence, Morbidity and Complications of Renal and Ureteral Calculin A Well Defined Geographical Area | Q67360689 | ||
| Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis | Q67401635 | ||
| Calcium oxalate stone disease: effects and side effects of cellulose phosphate and succinate in long-term treatment of absorptive hypercalciuria or hyperoxaluria | Q67430014 | ||
| Recurrent nephrolithiasis: natural history and effect of phosphate therapy. A double-blind controlled study | Q67487042 | ||
| Clinical aspects of polycystic kidney disease | Q67733976 | ||
| Hyperoxaluria in Patients with Recurrent Calcium Oxalate Calculi: Dietary and Other Risk Factors | Q67772730 | ||
| Inhibition by sodium-potassium citrate (CG-120) of calcium oxalate crystal growth on to kidney stone fragments obtained from extracorporeal shock wave lithotripsy | Q67962404 | ||
| Contrasting effects of various potassium salts on renal citrate excretion | Q67983181 | ||
| Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not | Q68130766 | ||
| Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients | Q68163303 | ||
| The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers | Q68233980 | ||
| Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate | Q68260013 | ||
| Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction | Q68701479 | ||
| Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria | Q69030188 | ||
| Assessment of the pathogenetic role of physical exercise in renal stone formation | Q69425143 | ||
| The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment | Q69427198 | ||
| Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women | Q69611180 | ||
| Bioavailability of citrate from two different preparations of potassium citrate | Q69613514 | ||
| Effect of long-term thiazide therapy on intestinal calcium absorption in patients with recurrent renal calculi | Q69733500 | ||
| Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect | Q69759028 | ||
| Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism | Q69814475 | ||
| Long-term treatment of calcium nephrolithiasis with potassium citrate | Q69897051 | ||
| Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate | Q69989091 | ||
| The effect of oral sodium phosphate on the formation of renal calculi and on idiopathic hypercalcuria | Q70068298 | ||
| Urinary excretion of oxalate by patients with renal hypercalciuric stone disease. Effect of chronic treatment with hydrochlorothiazide | Q70137677 | ||
| Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study | Q70279032 | ||
| Triamterene and renal stone formation | Q70291878 | ||
| Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization | Q70335780 | ||
| Relationships between Calcium and Oxalic Acid Intake in the Diet and Their Excretion in the Urine of Normal and Renal-Stone-Forming Subjects | Q70411033 | ||
| Enhancement of renal excretion of zinc by hydrochlorothiazide | Q70418592 | ||
| Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers | Q70421788 | ||
| Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis | Q70544133 | ||
| Use of Magnesium Oxide in Management of Familial Hyperoxaluria | Q70546741 | ||
| Metabolic effects of thiazide versus placebo in patients under long-term treatment for recurrent urolithiasis | Q70573684 | ||
| P433 | issue | 1 | |
| P921 | main subject | calcium oxalate | Q412399 |
| urolithiasis | Q1585769 | ||
| P304 | page(s) | 117-133 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Urologic Clinics of North America | Q15767454 |
| P1476 | title | Medical therapy, calcium oxalate urolithiasis | |
| P478 | volume | 24 |
| Q36051399 | Antiurolithiatic activity of ethanol leaf extract of Ipomoea eriocarpa against ethylene glycol-induced urolithiasis in male Wistar rats |
| Q57593569 | Characteristics of pediatric urolithiasis in south-east Anatolia |
| Q36314974 | Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria |
| Q37401624 | Evidence for durable kidney stone prevention over several decades |
| Q24548519 | Microbial relatives of the seed storage proteins of higher plants: conservation of structure and diversification of function during evolution of the cupin superfamily |
| Q45891351 | Parsley! Mechanism as antiurolithiasis remedy |
| Q35088685 | Prospective randomized clinical trial comparing phytotherapy with potassium citrate in management of minimal burden (≤8 mm) nephrolithiasis |
| Q35856098 | Protocol-based metabolic evaluation in high-risk patients with renal stones in North India |
| Q58118264 | Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date? |
| Q40778495 | The influence of a low protein diet in idiopathic hypercalciuria |
| Q83912206 | [The role of thiazides in the prophylaxis of recurrent calcium lithiasis] |
Search more.